12h
GlobalData on MSNBambusa Therapeutics doses first volunteers in Phase I bispecific AD trialThe Phase I trial will recruit approximately 98 healthy volunteers and adults living with atopic dermatitis at a single site ...
A PS2 series that got its starts in 2004 looks poised to return with a new release, according to a new Bandai Namco leak.
4h
Hosted on MSNSmackDown live blog: Elimination Chamber go homeFollow along with this week’s episode, the last stop before the Elimination Chamber PLE. Cody Rhodes speaks, and more!
This’ll be our eighth year.” Our, being Sirianni and Kevin Patullo. Year, being yet another offseason cycle together. Fitting ...
19h
The i Paper on MSN'I'm not expecting a state pension': how under-40s are prepping for retirementSeveral young people have spoken about their retirement saving habits - and their low expectations for the state pension ...
Tryn Stimart; Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer; Abcellera Biologics Inc. Carl L. Hansen; CEO, President & Chairper ...
Sony just pulled a fast one on us: the PlayStation VR2 is now $399, down from $549 as of March 2025. That’s a $150 price drop ...
The British media are jumping out of their pants, presenting the results of Prime Minister Keir Starmer's visit to US ...
Lazarus, the latest anime from the creator of Cowboy Bebop and Samurai Champloo, has a release date, and it's pretty soon.
It is a sandwich with the rarest of fillings. Researchers have unveiled berkelocene, a compound containing the synthetic element berkelium nestled neatly between two ring-shaped molecules (Science ...
The FDA approved the investigational new drug application for a phase 1 trial of ADCE-T02 in advanced solid tumors.
Gubra released its Annual Report for 2024. Significant progress was made in 2024 across several R&D projects, not the least by advancement of the anti-obesity Amylin program where positive topline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results